Patent · US Active

Compounds

US9737544B2 · kind B2 · utility

16Cited by
25References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 19, 2016
Grant dateAug 22, 2017
Priority date
Expiry dateJan 19, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to new pyridopyrazine and naphthyridine derivative compounds, to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.